A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
NCT06739122
This study is recruiting at 40 US sites in 25 states, according to its ClinicalTrials.gov record last updated .
Summary
The main purpose of this study is to evaluate additional dosing options for dulaglutide in pediatric participants with Type 2 Diabetes. Participation in this study will last about 8 months.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Type 2 Diabetes
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 3
- Ages
- 10 to 17 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Eli Lilly and Company
- Last updated on ClinicalTrials.gov
- August 7, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Arizona · 1
- University of Arizona · Tucson, AZ
Arkansas · 1
- Arkansas Childrens Hospital · Little Rock, AR
California · 3
- Division of Endocrinology, Diabetes, and Metabolism · Los Angeles, CA
- UCLA Mattel Children's Hospital · Los Angeles, CA
- University of California, San Francisco · San Francisco, CA
Connecticut · 1
- Yale Diabetes Research · New Haven, CT
District of Columbia · 2
- Children's National Medical Center · Washington D.C., DC
- Emerson Clinical Research Institute · Washington D.C., DC
Florida · 5
- Nemours Children's Health · Jacksonville, FL
- D&H National Research Centers, Inc · Miami, FL
- AdventHealth Orlando · Orlando, FL
- D&H Tamarac Research Center, LLC · Tamarac, FL
- University of South Florida · Tampa, FL
Georgia · 2
- Children's Healthcare of Atlanta - Center for Advanced Pediatrics · Atlanta, GA
- Centricity Research Columbus Endocrinology · Columbus, GA
Idaho · 1
- St. Luke's Children's Endocrinology and Diabetes · Boise, ID
Illinois · 1
- University of Illinois at Chicago · Chicago, IL
Indiana · 1
- Center for Diabetes and Metabolic Diseases Indiana University · Indianapolis, IN
Iowa · 1
- University of Iowa Stead Family Children's Hospitals · Iowa City, IA
Kentucky · 1
- Norton Children's Endocrinology · Louisville, KY
Maryland · 1
- Johns Hopkins University School of Medicine · Baltimore, MD
Mississippi · 1
- University of Mississippi Medical Center · Jackson, MS
New Mexico · 1
- University of New Mexico Hospital · Albuquerque, NM
New York · 3
- WBMD Pediatrics · Buffalo, NY
- Cohen Children's Medical Center Division of Pediatric Endocrinology · Hyde Park, NY
- SUNY Upstate Medical University · Syracuse, NY
North Carolina · 1
- UNC Children's Hospital · Chapel Hill, NC
Ohio · 2
- Childrens Hospital Medical Center · Cincinnati, OH
- Cleveland Clinic Childrens Outpatient Center · Cleveland, OH
Oklahoma · 1
- University of Oklahoma Health Sciences Center · Oklahoma City, OK
Pennsylvania · 2
- Children's Hospital of Philadelphia · Philadelphia, PA
- St Christophers Hospital For Children · Philadelphia, PA
South Carolina · 2
- Prisma Health Pediatric Endocrinology · Columbia, SC
- Prisma Health Midlands · Greenville, SC
Texas · 3
- Research Institute of Dallas · Dallas, TX
- Texas Childrens Hospital · Houston, TX
- UT Health Houston · Houston, TX
Utah · 1
- University of Utah · Salt Lake City, UT
Washington · 1
- Seattle Children's Hospital · Seattle, WA
Wisconsin · 1
- Children's Wisconsin - Milwaukee Campus · Milwaukee, WI
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.